Heron Therapeutics, Inc.
NASDAQHeron Therapeutics has rallied nearly 19% in a week — but short sellers are not flinching. That tension defines the setup heading into Q1 results. The stock closed at $1.21 on April 28, up 54% over the past month. Yet short interest has climbed alongside the price, rising 3.8% week-on-week to 22.4% of the free float. The divergence between price action and positioning is the…
Snapshot as of 11 May 2026
Heron Therapeutics has rallied nearly 19% in a week — but short sellers are not flinching. That tension defines the setup heading into Q1 results. The stock closed at $1.21 on April 28, up 54% over the past month. Yet…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for HRTX — free to start on ORTEX.
Sign up for free →Open HRTX on ORTEX